Sequenom (SQNM) Posts Q1 Profit of $0.12/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Caribou Biosciences to halt CAR-T programs, explore sale
- Sportradar to sell Synergy Sports coaching unit for $170M
- Emera and Canadian Utilities agree to merge in $72B all-share deal
Oppenheimer Sees Increased Clarity at Sequenom (SQNM)
May 8, 2015 11:27 AM EDTOppenheimer analyst Ling Wang reiterated an Outperform on Sequenom (NASDAQ: SQNM) following Q1 results, saying gaining clarity on royalty conversion.
Wang commented, "Slightly soft diagnostic revenues were offset by new licensing fee revenue from the patent pool. The final payment... More
Wedbush Downgrades Sequenom (SQNM) to Neutral
May 7, 2015 8:41 AM EDTWedbush downgraded Sequenom (NASDAQ: SQNM) from Outperform to Neutral with a price target of $4.50 (unchanged).
For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.
Shares of Sequenom closed at $4.47 yesterday.
... More


